Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer
Conditions
- Recurrent Endometrial Carcinoma
Interventions
- BIOLOGICAL: bevacizumab
- OTHER: laboratory biomarker analysis
Sponsor
National Cancer Institute (NCI)
Collaborators